NCT00092664View on ClinicalTrials.gov

An Extension Study of An Investigational Drug in Patients With Hypercholesterolemia (0653A-038)(COMPLETED)

PHASE3CompletedINTERVENTIONAL

Enrollment

1,104

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions

Hypercholesterolemia

Interventions

DRUG

MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 14 weeks

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00092664 - An Extension Study of An Investigational Drug in Patients With Hypercholesterolemia (0653A-038)(COMPLETED) | Biotech Hunter | Biotech Hunter